Direction
Buy
Sell
Types
LMT Order
Price
QTY
Amount
--
CYCN Cyclerion Therapeutics
0.698+0.015+2.20%
Close
02/06 16:00 ET
High
0.800
Open
0.700
Turnover
40.52K
Low
0.664
Pre Close
0.683
Volume
57.66K
Intraday
5D
1D
1W
1M
1Q
1Y
Price Forecast
News
Comment
Head-To-Head Review: Cyclerion Therapeutics (NASDAQ:CYCN) & Immutep (NASDAQ:IMMP)
Cyclerion Therapeutics (NASDAQ:CYCN – Get Rating) and Immutep (NASDAQ:IMMP – Get Rating) are both small-cap medical companies, but which is the superior investment? We will contrast the two companies
Cyclerion Therapeutics Receives Notice Of Allowance For Patent Application Titled "NOVEL PROCESSES AND INTERMEDIATES FOR THE PREPARATION OF SOLUBLE GUANYLATE CYCLASE STIMULATORS".
Cyclerion Therapeutics Receives Notice Of Allowance For Patent Application Titled "NOVEL PROCESSES AND INTERMEDIATES FOR THE PREPARATION OF SOLUBLE GUANYLATE CYCLASE STIMULATORS".
Cyclerion Therapeutics (NASDAQ:CYCN) Stock Price Down 6.4%
Shares of Cyclerion Therapeutics, Inc. (NASDAQ:CYCN – Get Rating) fell 6.4% during trading on Monday . The stock traded as low as $0.78 and last traded at $0.82. 161,207 shares changed hands during m
Why American Eagle Outfitters Shares Climbed Over 18%; Here Are 78 Biggest Movers From Yesterday
Gainers Cosmos Holdings Inc. (NASDAQ:COSM) jumped 86.9% to close at $0.3275 on Tuesday after jumping 21% on Monday. Cosmos Health agreed to sell its Sky Premium Life Luxury food supplement brand on Ib
Why Dollar Tree Shares Are Trading Lower By 10%? Here Are 53 Stocks Moving In Tuesday's Mid-Day Session
Gainers Palisade Bio, Inc. (NASDAQ:PALI) shares jumped 99.1% to $4.42 after the company announced the FDA granted Fast Track designation to LB1148 for the acceleration of time to return of bowel func
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
GainersOncoSec Medical (NASDAQ:ONCS) shares rose 31.9% to $6.4 during Tuesday's pre-market session. The market value of their outstanding shares is at $11.4 million. TransCode Therapeutics (NASDAQ:RNA
Cyclerion Shares Rise After Spurned Bid for Assets
By Colin Kellaher Shares of Cyclerion Therapeutics Inc. rose more than 15% in premarket trading Tuesday after the clinical-stage biopharmaceutical company said it had rejected an unsolicited acquisit
Cyclerion Concludes Unsolicited Proposal Is Not in The Best Interest of The Company
CAMBRIDGE, Mass., Nov. 22, 2022 (GLOBE NEWSWIRE) -- Cyclerion Therapeutics, Inc. (Nasdaq: CYCN) today announced that the Board of Directors of the Company acting solely by all of its independent and
Why ObsEva Shares Are Trading Higher By Over 70%; Here Are 21 Stocks Moving Premarket
Gainers ObsEva SA (NASDAQ:OBSV) shares rose 71.9% to $0.2848 in pre-market trading after the company reported the sale of Ebopiprant license agreement to XOMA for up to $113 million.Secoo Holding Limi
Cyclerion Therapeutics Third Quarter 2022 Earnings: US$0.24 Loss per Share (Vs US$0.26 Loss in 3Q 2021)
Company Overview
More
Cyclerion Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the discovery, development, and commercialization of treatments for serious and orphan diseases, through the use of soluble guanylate cyclase (sGC) pharmacology. Its product pipeline includes several sGC stimulators, a small molecules that act synergistically with nitric oxide on sGC to boost production of cyclic guanosine monophosphate (cGMP). The company was founded on September 6, 2018 and is headquartered in Cambridge, MA.
CEO： Mr. Peter M. Hecht, PhD
Market： NASDAQ
Listing Date： 03/18/2019
Paper Trade
More
Hot List
TradeSearchNews
SymbolLatest price%Chg
Loading...
Watchlist
No Stock Yet